chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Provider summary "91 YO male with a PMHx of asthma, OSA, pulmonary hypertension, CKD stage 3, type 2 diabetes, obesity who presents with dyspnea on exertion and cold-like symptoms for a few days.   Patient is an incredibly poor historian and frequently falls asleep during exam.  He cannot tell me even why he came to the hospital.  He denies any current pain and denies any current trouble breathing.  Called patient's DPOA  and left voicemail.  Also discussed with daughter.  She told me that patient had been feeling sick for approximately a week.  He predominantly complained of myalgias and not trouble breathing.  ER notes that he complained of shortness of breath for the last few days.   Reportedly was vaccinated with 2 doses of the vaccine but did not obtain booster.   In the ED:  Initially required non-rebreather due to hypoxia PICC.  Quickly weaned to room air, but needs oxygen while sleeping due to known OSA.  Labs notable for COVID positive, AKI with a creatinine of 1.9.  CT pulmonary embolism negative for PE.   He was weaned fairly quickly off of BiPap support to nasal cannula. His mentation quickly improved as well. He was continued on dexamethasone and remdesevir while admitted. He was eventually weaned to room air but needed O2 with activity. He was seen by PT/OT recommended SNF v home with assist. He adamantly refuse SNF placement. His care was discussed wit his daughter and caregiver. They all agreed that he could come home. He was discharged in stable condition with strict return precautions. "
When assessing child for immunizations I inadvertently gave Kinrix at 7 years of age instead of seperare DTaP and Polio.
Severe chills 12&1/2 hours after covid shot followed by severe horrible muscle aches for the 24 hours. Fatigue for following 24 hours.
94 yo F presented from assist living with slur speech for 1 day, last seen well on 1/30. Pt has a PMH of dementia (Baseline, she will keep saying, "help me, help me", AOX3, using walker, could go to bathroom by herself), hx breast cancer (s/p lumpectomy, chemo, Tamoxifen, currently not on tx), HTN, HLD, vaginal bleeding (no further work up by family), overactive bladder (on solifenacin), hx of MI (undocumented, no PCI or CABG), spine stimulator placed. According to patient's daughter, she saw her January 30, she was doing okay after the vaccine. On  1/31 when the daughter called her on the phone, she knows she has some slurred speech, when she saw patient in the facility, she noticed her gait becomes unsteady.  She decided to bring her to the hospital.  1/30, she noticed the patient has spilled up some water, otherwise denies fever, chills, shortness of breath, pain,  chronically, she has constipations taking laxative.  In the ED, pt was afebrile, 36.1, heart rate 85, blood pressure 130/61, respiratory rate 18, saturations 98 on room air.  Labs shows, sodium 134, potassium 3.6, bicarb 28, BUN 18, creatinine 0.97, glucose 119, WBC 12.5, hemoglobin 11.8, platelet 239.  PT INR 1.09, COVID negative. CT head suggestive of subacute infarct. Possible including small vessel ischemic changes. Chest xray questionable patchy left retrocardiac atelectasis or pneumonia. EKG shows atrial fibrillation's heart rate 71, QTc 610.  Case was discussed with neurology in the ED, patient was not a TPA or embolectomy candidate. CT head suggestive of acute/subacute cerebellar infarct.  Patient does not have any residual or sensory deficit except expressive aphasia. Neuro saw patient,  mentioned patient appears to have had a stroke that by the CAT scan criteria is already subacute.  The patient was admitted on the stroke pathway.   The patient has new onset atrial fibrillation and therefore should be considered for anticoagulation.  The patient cannot have an MRI of the brain due to her spinal cord stimulator but given that the stroke is already subacute on the CT without any signs of hemorrhagic conversion she could be started on this at this point.  If she gets started on anticoagulation the aspirin should be stopped. If the patient cannot go on anticoagulation or does not want to then she might be a candidate for dual antiplatelet therapy for secondary stroke prevention. 2D echo shows normal ejection fraction of the left ventricle estimated at 70 to 75%.  Regional wall motion abnormality was not observed.  Right ventricle systolic function is normal.  Moderate aortic stenosis. Cardio was consulted for anticoagulation,  From cardioembolic prevention standpoint, anticoagulation is recommended to prevent CVA. However, she has significant risks for bleeding given recent vaginal bleeding (investigation not pursued to spare her comfort), age, comorbidities, etc. Again, further discussion between family and primary team is required regarding risks vs benefits. Was evaluated by speech-language pathology present minimal oral dysphagia no overt clinical signs of aspiration, recommended to continue with NDD 2 diet/thin liquid. Patient was discharged to ECF.
Tingling in arm within 15 minutes  Extreme itching - arms - a couple of hours later  Pins and needles in both arms and both legs alternating with itching
Adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Adverse reaction). At the time of the report, ADVERSE REACTION (Adverse reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Very limited information regarding this event/s has been provided at this time.  Further information has been requested, however causal relationship of the adverse reaction after the vaccination, even with unknown date,  cannot be excluded .; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested, however causal relationship of the adverse reaction after the vaccination, even with unknown date,  cannot be excluded .
Within 4 hours after receiving the vaccine, I developed a hissing sound in both ears. 26 hours later it is still prevalent. I?ve never had hissing before in my ears but have had some clicking occasionally. I also had a low grade fever, mild body aches and a headache, which lasted 24 hours.
Swollen arm at injection site, very warm and sore to the touch, and had redness where shot was given.  Two doctors revealed it was a 7x8 cm cellulitis.
Pt received DTAP, IPV and MMR on 3/15/2000. Grandmother called on 3/16/2000 to report that child was experiencing fever (unknown how high), diarrhea 3 times today, vomited twice and had dry heaves, chills and abdominal pain. Grandmother was treating child with Tylenol and Advil.
Approximately 5 minutes after vaccination, patient fainted and fell out of chair she was waiting in for post-vaccine observation. She fell on her right said on to the floor. I conducted a physical assessment for bruises, bleeding, broken bones, etc. as well as assessment for breathing and pulse. She was responsive to commands. We followed our emergency protocol and called EMS, who arrived within 5 minutes to further assess the patient. They obtained BP, pulse, and blood sugar readings (I am not aware of the results of those readings). Patient denied emergency transport to hospital, and left the facility about 30 minutes after vaccination with her mother to drive her.
Tingling sensation in her arm, neck, feet, muscles and back; Uncomfortable; Back pain; Whole body was hurting me; Inflammatory situation; Nerve pain; Trouble in putting shoes on and is uncomfortable when things touch her feet; Body felt different; Kind of like flu feeling; Low fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation in her arm, neck, feet, muscles and back), DISCOMFORT (Uncomfortable), BACK PAIN (Back pain), PAIN (Whole body was hurting me) and INFLAMMATION (Inflammatory situation) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Operation NOS (Patient had operation on neck 1 year ago). Previously administered products included for Product used for unknown indication: Flu vaccine (Patient had a 1 day reaction to flu vaccine taken about 1 month ago.).   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Kind of like flu feeling), PYREXIA (Low fever) and CHILLS (Chills). On an unknown date, the patient experienced PARAESTHESIA (Tingling sensation in her arm, neck, feet, muscles and back), DISCOMFORT (Uncomfortable), BACK PAIN (Back pain), PAIN (Whole body was hurting me), INFLAMMATION (Inflammatory situation), NEURALGIA (Nerve pain), LIMB DISCOMFORT (Trouble in putting shoes on and is uncomfortable when things touch her feet) and FEELING ABNORMAL (Body felt different). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at an unspecified dose and frequency and Physical therapy for Back pain. On 18-Feb-2021, INFLUENZA LIKE ILLNESS (Kind of like flu feeling), PYREXIA (Low fever) and CHILLS (Chills) had resolved. At the time of the report, PARAESTHESIA (Tingling sensation in her arm, neck, feet, muscles and back), DISCOMFORT (Uncomfortable), BACK PAIN (Back pain), PAIN (Whole body was hurting me), INFLAMMATION (Inflammatory situation), NEURALGIA (Nerve pain), LIMB DISCOMFORT (Trouble in putting shoes on and is uncomfortable when things touch her feet) and FEELING ABNORMAL (Body felt different) outcome was unknown.            No concomitant medications were provided.   Patient tried acupuncture , steroid shot for back , therapy and physical therapy. Patient talked to multiple HCP's who have not been able to give patient a diagnosis.   This case was linked to MOD-2021-373689 (Patient Link).
Information has been received from a physical therapist(PT) concerning an adult patient who was vaccinated with a dose of hepatitis B virus vaccine rHBsAg(yeast). The pt reported that the patient subsequently developed secondary fibromyalgia. Unspecified medical attention was sought. At the time of the time of this report, the outcome was unknown. The Pt felt  that the secondary fibromyalgia was related to the hepatitis b virus vaccine rHBsAg (yeast). Additional infomation has been requested.
Patient had a ground level fall, she landed on the right side of her head, this occurred while she was "warming up" to run track.  EMS called. Bystanders suggest there might have been some seizure-type activity.
Child was complaining of itching of left leg, mom noted big red area around where the Kinrix had been given - following day was seen in the clinic with measurements of 10cm x 17cm of erythema/induration and warmth, no tenderness, no itching at time of visit.
my grandfather suffered a stroke affecting his left side. it took us over a day to conceive him to see a Dr. he was finally taken by ambulance to our local hospital and transferred to another hospital about an hour away. they did multiple tests to make sure he wasn't in further danger and released him to the care of my mother. it didn't damage his ability to think. he struggles to speak, swallow, and walk, and can't move his arm at all.
Bump on her arm (about 1/4 inch high with diameter 1 1/2 inches), hot to the touch noticed on 09.27.18. Discomfort on the first few days and itchiness starting 09/30/2018, then improving now.
Pfizer-BioNTech COVID-19 Vaccine EUA Lot# EN6204 Fatigue, nausea, vomiting, aches from 3/24/21 to present. Can't eat due to nausea. Diabetes blood sugars went way up during 3/24/21 to 3/26/21, but returned to normal to low range thereafter. Still nausea and occasional vomiting today, 3/31/21. Can only keep crackers  and water down, but physician office says that's ok, just to keep an eye on my blood sugars. Still fatigued as well, more than usual.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On 27-JAN-2014, the patient was vaccinated with a dose of improperly stored PEDVAXHIB lot # reported as J005672, expiration date reported as 05-DE3C-2015 (dose and route were not reported). No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccines have undergone several temperature excursions and may have been administered to patients) and NO ADVERSE EVENT (No adverse event) in a 37-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Sep-2022 at 8:58 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 26-Sep-2022 at 8:58 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccines have undergone several temperature excursions and may have been administered to patients). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccines have undergone several temperature excursions and may have been administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.
Information has been received from a physician concerning a 7 year old male who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and "came down with chickenpox". The physician did not know whether the patient had one shot or two of the vaccine. No additional information was provided. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Around December 9, I began having cold symptoms. Symptoms did not improve and I began having nose bleeds when I would cough. I went to urgent care and was diagnosed with a sinus infection. I was prescribed amoxicillin and told to switch to Claritin from Zyrtec. Completed course of Amoxicillin and symptoms improved during treatment but returned much worse when antibiotic was completed. Returned to a different urgent care clinic and was tested for Flu, RSV, and COVID-19, all were negative. They stated that the sinus infection was still present and was prescribed  augmentin,  sudafed  , and nasal rinse with saline.  After completing augmentin I continued with sudafed  and nasal rinse due to residual congestion. Congestion cleared up around the end of January.
Could not see; Sweating; Dizzy; Legs were weak.; Chills; This is a spontaneous report from a contactable consumer or other non hcp. A 13-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: Not reported), via an unspecified route of administration on 29Aug2021 12:45 (at the age of 13-Years-old) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took amoxicillin (when she was 2-years-old) and clindamycin (when she was 12-years-old) and experienced urticaria. The patient experienced could not see, sweating, dizzy, legs were weak and chills on 30Aug2021 at 05:00. The adverse event could not see was considered as serious with seriousness criteria of medically significant and remaining events were non-serious. Patient mother reported her daughter is fine now and wanting to know is this normal and what will happen with a second dose and she is worried about the second dose and how she will react. The outcome of the events were reported as recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Mar2021 12:00 (Lot number: ER8733) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergies: Bee venom" (unspecified if ongoing). Concomitant medication(s) included: TAMOXIFEN. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EH6206, Location of injection: Arm Left, Vaccine Administration Time: 01:30 PM), administration date: 06Mar2021, for COVID-19 immunization. The following information was reported: TINNITUS (non-serious) with onset 28Mar2021, outcome "not recovered", described as "tinnitus". The event "tinnitus" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of tinnitus. Prior to vaccination, was the patient diagnosed did not diagnosed with COVID-19 and since the vaccination, patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Flu shot given at another clinic. We are the PCP. Seen today 10-30-18. 10-21-18 - abnormal, involuntary movements began - had occurred everyday. Seen today while here at visit 10-30-18.
Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 11-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter. Reporter stated that it was unknown if the doses was first, second or third for the patient. Reporter also reported that vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. Reporter also said that vials did not undergo any temperature excursion.
Pt deceased r/t STEMI/ Cardiogenic Shock/ Ascending aortic dissection
Scheduled for a #2 Hepatitis B vaccine, but no record of Hepatitis B on record.  Spoke with patient, she stated she had Hep B series as a child and just needs 2nd Hepatitis A. Hepatitis A vaccine given to patient. Printed record and it showed she needed another Hepatitis A vaccine.  Spoke with another nurse and investigated further to realize the dose had been given 2 months earlier than recommended.  Called patient to notify her of error and explained she would need to come back after April 28, 2023 for repeat Hepatitis A vaccine.  Patient verbalized understanding.  Charted this information in chart.
The patient was given a Pfizer booster third dose, which is not eligible for the age of 15 years old (patient's age) under the current CDC guidelines. Patient reports no adverse reactions upon administration during observation periods of 15 minutes. In addition, the patient was not eligible for the booster at the time of visit.
Sore injection site evening of shot Woke up the next morning with fever, lethargic, breast felt swollen and were very tender, arm more sore.  Felt this way until about 10 pm. Symptoms started subsiding. Woke up 3/4 and no symptoms other than sore arm. Arm was sore until 3/6.
ER visit 2-22-08.  Complained of redden, firm area, left thigh onset 2-22-08 AM.  No fever.  Area left thigh 3x8cm per ER doctor.  Treatment: warm compresses septra susp.
blurred vision; Pounding in her chest; dizziness; weakness; lack of appetite; lung pain; chest pain; sweating; coughing; fever; tiredness; headache; Body aches; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VISION BLURRED (blurred vision), PALPITATIONS (Pounding in her chest), DIZZINESS (dizziness), ASTHENIA (weakness) and DECREASED APPETITE (lack of appetite) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VISION BLURRED (blurred vision), PALPITATIONS (Pounding in her chest), DIZZINESS (dizziness), ASTHENIA (weakness), DECREASED APPETITE (lack of appetite), PULMONARY PAIN (lung pain), CHEST PAIN (chest pain), HYPERHIDROSIS (sweating), COUGH (coughing), PYREXIA (fever), FATIGUE (tiredness), HEADACHE (headache) and MYALGIA (Body aches). At the time of the report, VISION BLURRED (blurred vision) had resolved and PALPITATIONS (Pounding in her chest), DIZZINESS (dizziness), ASTHENIA (weakness), DECREASED APPETITE (lack of appetite), PULMONARY PAIN (lung pain), CHEST PAIN (chest pain), HYPERHIDROSIS (sweating), COUGH (coughing), PYREXIA (fever), FATIGUE (tiredness), HEADACHE (headache) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 104 degrees f High. On 08-Mar-2021, Heart rate increased: elevated pulse High. On 10-Mar-2021, Body temperature: 101 degrees f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
I had Chills and a feverous reaction, I was cold and sweating at the head. My body ached all night from the time I laid to rest from the body aches from 7:30 pm to 9:00 am in the morning the next day.
Onset of flu-like symptoms ~4 hours after reciept of vaccine (e.g., myalgia, malaise, fatigue).  Onset of bilateral red eyes with some pruititis, sore throat and URI symptoms ~24 hrs after receipt of vaccine.  No fever / chills.
on 8-13-19 started as red spot, then noticed redness and swelling to L upper arm, got bigger throughout day, redness spread but swelling seems improved - on exam L arm deltoid area w approximately 2"x2" erythematous sl firm and tender area, warm to touch, full rom, no streaking, sl raised - Dx:  Cellulitis of Left Upper extremity - Tx:  Amoxicillin-Pot Clavulanate 400-57mg take 2 chewable tabs Q12 hours for 10 days.
Received DTaP/Hib 09/27/2001. Evening of 09/28/2001 immunization site noted to be red, swollen and warm to touch. No pain, fever. Compresses applied. Seen in office 09/29/2001. Symptom improving but chill with 8 X 10 cm area of in duration and erythema. Nontender. Treated symptomatically.